-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Axsome Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2016 to 2024.
- Axsome Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was $85K.
- Axsome Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2024 was $85K, a 91.1% decline year-over-year.
- Axsome Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2024 was $85K, a 91.1% decline from 2023.
- Axsome Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $960K.
- Axsome Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)